Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
10/2000
10/24/2000US6136560 Amidotransferase, ratB, of streptococcus pneumoniae
10/24/2000US6136557 Strepococcus pneumoniae gene sequence FtsH
10/24/2000US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2065439C Expression of herbicide metobolizing cytochromes p450
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061810A1 Antisense oligonucleotides comprising universal and/or degenerate bases
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061787A2 gyrA
10/19/2000WO2000061785A2 Polynucleotide and polypeptide sequences of monkey cathepsin k
10/19/2000WO2000061781A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000WO2000061780A1 Compositions and methods for extending life span
10/19/2000WO2000061778A1 Staphylococcus aureus mvaa
10/19/2000WO2000061776A1 Vitamin d derivatives and process for producing the same
10/19/2000WO2000061771A2 Transgenic plants containing altered levels of sterol compounds and tocopherols
10/19/2000WO2000061769A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS
10/19/2000WO2000061768A2 Preparation of biologically active molecules
10/19/2000WO2000061767A1 Extracellular protease from $i(acremonium chrysogenum) with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061765A2 Lipoxygenase proteins and polynucleotides encoding the same
10/19/2000WO2000061764A1 Carotene hydroxylase and method for producing xanthophyll derivatives
10/19/2000WO2000061763A2 Proteins related to gaba metabolism
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061734A2 Enzyme compositions and their use as catalysts
10/19/2000WO2000061733A1 Xylose isomerase with improved properties
10/19/2000WO2000061732A1 α-GLYCATED AMINO ACID RELEASING ENZYME
10/19/2000WO2000061731A2 Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
10/19/2000WO2000061730A1 Glucose dehydrogenase
10/19/2000WO2000061728A2 Human elastase i
10/19/2000WO2000061727A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use
10/19/2000WO2000061723A1 L-amino acid-producing bacteria and process for producing l-amino acid
10/19/2000WO2000061721A1 Method for obtaining $i(a. niger) cultures and their uses for producing ferulic acid and vanillic acid
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061617A2 Transiently immortalized cells for use in gene therapy
10/19/2000WO2000061609A2 Prodrugs of thrombin inhibitors
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061577A1 Prodrugs of thrombin inhibitors
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061179A1 Kringle domains of plasminogen, capable of modulating angiogenesis in vivo
10/19/2000WO2000060933A1 Pkc induced targets
10/19/2000WO2000039779A3 Hinge structure
10/19/2000WO2000039290A8 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
10/19/2000WO2000034485A3 Beta-1,3-galactosyltransferase homologs
10/19/2000WO2000032793A3 Plant cell derived diacylglycerol acyltransferases
10/19/2000WO2000028008B1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000WO1999067381A9 Treatment of staphylococcus infections
10/19/2000DE19916929A1 New oligonucleotide primers, useful for amplifying human telomerase RNA for diagnosis, prognosis and monitoring of cancer
10/19/2000DE19916242A1 PSA-haltige Substanz und deren Verwendung PSA-containing substance and its use
10/19/2000DE19915938A1 Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung Production of pancreatic procarboxypeptidase B isoforms and its muteins and their use
10/19/2000CA2372120A1 Transgenic plants containing altered levels of sterol compounds and tocopherols
10/19/2000CA2370267A1 Prodrugs of thrombin inhibitors
10/19/2000CA2370114A1 Method for obtaining a. niger cultures and their uses for producing ferulic acid and vanillic acid
10/19/2000CA2369996A1 Compositions and methods for extending life span
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2368953A1 Proteins related to gaba metabolism
10/19/2000CA2368830A1 Prodrugs of thrombin inhibitors
10/19/2000CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000CA2365984A1 Antisense oligonucleotides comprising universal and/or degenerate bases
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365919A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same
10/19/2000CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000CA2365906A1 Carotene hydroxylase and method for producing xanthophyll derivatives
10/19/2000CA2365901A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000CA2364565A1 Glucose dehydrogenases
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2360318A1 A second mammalian tankyrase
10/18/2000EP1045250A1 A global test for evaluating the functionality of the thrombin/antithrombin system
10/18/2000EP1045028A1 Deoxyribonucleases
10/18/2000EP1045027A1 Novel gene having reverse transcriptase motif
10/18/2000EP1045026A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
10/18/2000EP1045025A1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE
10/18/2000EP1044278A1 Biosynthesis of medium chain length polyhydroxyalkanoates
10/18/2000EP1044277A2 Recombinant, active caspases and uses thereof
10/18/2000EP1044276A2 Proteases from gram positive organisms
10/18/2000EP1044275A1 Mammalian matrix-type metalloprotease
10/18/2000EP1044264A2 Branched chain amino acid biosynthetic enzymes
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270636A DNA sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants
10/18/2000CN1270634A Vertebrate telomerase genes and proteins and uses thereof
10/18/2000CN1270224A DNA molecules of aminopeptidase with new code and production of the aminopeptidase
10/18/2000CN1270223A Method for producing L-argenine and synthesising emzyme gene by carbamyl phosphoric acid of corynebacterium
10/18/2000CN1057568C Process for preparation of D-alpha-amino acids
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/17/2000US6133506 Keto-acyl-(ACP) reductase promoter from cuphea lanceolata
10/17/2000US6133505 Phytopathogenic geminivirus resistant transgenic plants and seeds and methods for obtaining same by introduction of mutated C1 gene
10/17/2000US6133504 Transgenic plant tolerant to sodium chloride stress containing a foreign dna encoding a gene for reductase enzyme operably linked to a heterologous promoter
10/17/2000US6133438 Alkylating unblocked cytidine to form 2'-o-alkylated cytidine, blocking the 5'-hydroxyl moiety, and phosphitylating the 3'-position
10/17/2000US6133421 Polypeptides and polypeptide subunits of a stereospecific nitrile hydratase enzyme
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133417 Enzyme catalyzes conversion of amino acid to corresponding n-hydroxyamino acid and then into corresponding oxime; for transgenic plants resistant to insects, acarids, or nematodes or plants with improved nutritive value
10/17/2000US6133416 Inhibition of cell growth by an anti-proliferative factor